
BACKGROUND: Percutaneous cholecystostomy (PC) is used for acute cholecystitis when immediate cholecystectomy is unsafe. We evaluated selection, treatment response, drain morbidity, subsequent surgery, and survival in a quaternary referral practice. METHODS: Adults undergoing PC from January 2016 to August 2025 were retrospectively reviewed, with follow-up to September 2026. Analyses assessed operative risk, Tokyo severity, 72-h response, drain outcomes, surgery and mortality, distinguishing planned interval from acute/rescue cholecystectomy. RESULTS: Eighty-one patients underwent PC over 9.7 years; 56.8% were interhospital transfers. Median age was 74.2 years; 97.5% were American Society of Anesthesiologists (ASA) Grade 3 or higher, 82.7% had American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) predicted mortality ≥ 10%, 72.8% had Tokyo Grade III disease and 51.9% were in septic shock. Clinical improvement within 72 h occurred in 91.4%. Drain complications occurred in 21.0% and recurrent biliary events in 17.3%. Forty patients (49.4%) underwent cholecystectomy: 32 planned interval and eight acute/rescue procedures. Median time to planned interval surgery was 108 days. Lower NSQIP risk and documented bridge-to-surgery intent were independently associated with planned interval cholecystectomy. One-year mortality was 28.8% (23/80); failure to improve within 72 h was associated with 85.7% one-year mortality versus 23.3% after improvement (p = 0.002). CONCLUSION: PC was used in a highly selected, severely unwell population and usually achieved early improvement, but drain morbidity and competing mortality remained substantial. Approximately two in five patients progressed to planned definitive surgery, supporting selective PC use when index operative risk is prohibitive.
ABSTRACT Importance Craniosynostosis, the premature fusion of cranial sutures, can cause abnormal skull shapes, neurological issues and aesthetic concerns. Surgical correction is standard, but planning is complex and operator‐dependent. Artificial intelligence (AI) offers the potential to enhance diagnosis, optimise planning and predict postoperative outcomes. Observations A scoping review following PRISMA‐ScR guidelines identified 11 studies involving paediatric patients with craniosynostosis. AI methods included unsupervised machine learning, convolutional neural networks, finite element models and variational autoencoders. Applications encompassed cranial severity scoring, phenotype classification, preoperative surgical simulation, intraoperative guidance and outcome prediction. AI‐derived metrics correlated strongly with expert assessments, facilitated patient‐specific planning and predicted postoperative aesthetics. Conclusions and Relevance AI is a transformative adjunct in craniosynostosis surgery. Clinically, it improves diagnostic accuracy, supports personalised surgical planning and guides intraoperative decision‐making. Some studies show AI can contribute to better functional and aesthetic outcomes, showing great promise in the paediatric surgical field. Although AI does not replace clinical expertise, it enhances precision and reproducibility. Future research should prioritise prospective validation, integration into surgical workflows and development of interpretable, surgeon‐friendly AI tools to maximise clinical benefit.
ABSTRACT Background Carpal tunnel syndrome (CTS) is a common peripheral nerve entrapment; open carpal tunnel release (OCTR) surgery is the gold standard surgical technique. Pre‐operative alcohol consumption is a known predictive factor of polyneuropathy and post‐operative outcomes. The aim is to investigate the influence of alcohol consumption on OCTR surgery outcomes. Methods A systematic review registered with PROSPERO was performed using PRISMA guidelines. Study selection included English language randomised controlled trials, cohort longitudinal studies and case series on adults published within a 10‐year period (2015–2025). ROBINS‐I was utilised for a risk of bias assessment. Results Eight studies were eligible as per the criteria. There is little to no evidence which suggests pre‐operative alcohol consumption impacts OCTR post‐operative outcomes ( p = 0.60); depression ( p = 0.46), Boston Carpal Tunnel Questionnaire (BCTQ) ( p = 0.16), palmar pain ( p = 0.27), wound healing disturbance ( p = 0.85), numbness ( p = 1.00), pain ( p = 0.50), Kelly Score ( p = 1.00) and return to work ( p = 0.67). There is varying evidence associating pre‐operative alcohol consumption with post‐operative infection; one study reported little to no evidence ( p = 0.39) and another reported very strong evidence ( p < 0.001). There is evidence to suggest that patients requiring revision surgery are less likely to consume alcohol ( p = 0.025). Conclusion There is little to no evidence that alcohol consumption impacts outcomes in patients undergoing OCTR surgery. Further studies should investigate the impact of pre‐operative alcohol consumption on post‐operative infection risk and revision surgery outcomes.